C93.01
Acute monoblastic/monocytic leukemia, in remission
Clinical Classification Guidelines
Medical Intelligence & Overview
Acute monoblastic/monocytic leukemia is a type of blood cancer that affects the monocyte cells, which are part of the immune system. When this leukemia enters remission, it means that signs of the disease are not currently detectable, although treatment might still be ongoing. This condition, coded as C93.01 in the ICD-10 classification, requires careful monitoring and management to prevent relapse and manage any lingering symptoms or side effects from treatment.
Causes & Symptoms
Clinical Causes: Genetic mutations that lead to abnormal monocyte production Exposure to certain chemicals or radiation Previous chemotherapy or radiation therapy for other cancers Inherited genetic factors, though rare Environmental factors that affect bone marrow function
Key Symptoms: Fever that persists or recurs Unexplained weight loss Fatigue and weakness Swollen lymph nodes or spleen Easy bruising or bleeding due to low blood platelets Pallor or pale skin caused by anemia Frequent infections or infections that are difficult to treat
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves multiple tests, including blood work to check for abnormal cells, bone marrow biopsies to analyze cell types and activity, and imaging studies if there is organ involvement. Since remission indicates the absence of detectable disease, ongoing monitoring through regular blood tests and medical evaluations are important for early detection of potential relapse.
Treatment Protocols: While remission signifies a positive response to previous treatment, ongoing management is crucial. Treatment options may include: - Maintenance therapy to sustain remission - Regular blood tests for monitoring - Supportive care to manage side effects and improve quality of life - Consideration of additional therapies if there is evidence of relapse Ultimately, treatment plans are tailored to the individual patient’s health status and response to previous therapies.
Clinical Advice & FAQs
Billing Guidance
Is C93.01 a billable ICD-10 code?
Yes, C93.01 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C93.01?
Clinical documentation must specify the nature of Acute monoblastic/monocytic leukemia, in remission and any associated comorbidities for accurate reporting.
Cite this Clinical Reference